JENNIE STORMES: Open Payments
NPI 1053955500 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,590 in 121 payments from 21 companies in 2025. Trend: 2023 $2,106 · 2024 $2,527 · 2025 $2,590
Food & beverage: $2,590
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 25 | $465 |
| Otsuka America Pharmaceutical, Inc. | 20 | $364 |
| Alkermes, Inc. | 20 | $363 |
| LivaNova USA, Inc. | 5 | $328 |
| Teva Pharmaceuticals USA, Inc. | 10 | $217 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $164 |
| Janssen Pharmaceuticals, Inc | 6 | $133 |
| E.R. Squibb & Sons, L.L.C. | 4 | $101 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $73 |
Products named: INGREZZA, ARISTADA, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, REXULTI, CAPLYTA, UZEDY, ABILIFY MAINTENA, COBENFY.
Industry payments across CO — which companies pay providers there.
